Showing results (41-50 of 132) with videos related to
Sort By:
Pageof 14
Intensive Care Medicine|May 13, 2008
Procalcitonin-a new diagnostic tool in complications following liver transplantationE R Kuse, I Langefeld, K Jaeger, et al.Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 8, 2000
Nutrition of liver transplant patientsA Weimann, M Plauth, S C Bischoff, et al.Critical Care Medicine|March 9, 2000
Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infectionE R Kuse, I Langefeld, K Jaeger, et al.Cancer Genetics and Cytogenetics|January 1, 1990
Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndromeS Suciu, R Kuse, H J Weh, et al.Virchows Archiv. A, Pathological Anatomy and Histology|January 1, 1975
[On the ultrastructure and cytochemistry of eosinophil-myelomonocytic leukemias]U Wulfhekel, J Düllmann, H Bartels, et al.Langenbecks Archiv Fur Chirurgie|January 1, 1989
Potential various appearances of hyperacute rejection in human liver transplantationG Gubernatis, J Kemnitz, A Bornscheuer, et al.Transplantation|June 29, 1999
Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapyM Schult, D Löhmann, W Knitsch, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 19, 2002
Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipientsGerit Niemeyer, Martina Koch, Susan Light, et al.Clinical and Laboratory Haematology|December 1, 1996
Automated reticulocyte counting for monitoring patients on chemotherapy for acute leukaemias and malignant lymphomasR Kuse, C Foures, J M Jou, et al.Klinische Wochenschrift|October 15, 1987
2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alphaA D Ho, R Kuse, O Prümmer, et al.Pageof 14